| Year |
Citation |
Score |
| 2021 |
Shapiro JA, Soman AV, Berkowitz Z, Fedewa SA, Sabatino SA, de Moor JS, Clarke TC, Doria-Rose VP, Breslau ES, Jamal A, Nadel MR. Screening for colorectal cancer in the United States: correlates and time trends by type of test. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34088751 DOI: 10.1158/1055-9965.EPI-20-1809 |
0.482 |
|
| 2021 |
Knudsen AB, Rutter CM, Peterse EFP, Lietz AP, Seguin CL, Meester RGS, Perdue LA, Lin JS, Siegel RL, Doria-Rose VP, Feuer EJ, Zauber AG, Kuntz KM, Lansdorp-Vogelaar I. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. Jama. 325: 1998-2011. PMID 34003219 DOI: 10.1001/jama.2021.5746 |
0.434 |
|
| 2021 |
Doria-Rose VP, Lansdorp-Vogelaar I, McCarthy S, Puricelli-Perin DM, Butera V, Segnan N, Taplin SH, Senore C. Measures of longitudinal adherence to fecal-based colorectal cancer screening: literature review and recommended approaches. International Journal of Cancer. PMID 33811643 DOI: 10.1002/ijc.33589 |
0.469 |
|
| 2021 |
Sabatino SA, Thompson TD, White MC, Shapiro JA, de Moor J, Doria-Rose VP, Clarke T, Richardson LC. Cancer Screening Test Receipt - United States, 2018. Mmwr. Morbidity and Mortality Weekly Report. 70: 29-35. PMID 33444294 DOI: 10.15585/mmwr.mm7002a1 |
0.548 |
|
| 2020 |
Doubeni CA, Corley DA, Jensen CD, Schottinger JE, Lee JK, Ghai NR, Levin TR, Zhao WK, Saia CA, Wainwright JV, Mehta SJ, Selby K, Doria-Rose VP, Zauber AG, Fletcher RH, et al. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer. Journal of Medical Screening. 969141320921427. PMID 32438892 DOI: 10.1177/0969141320921427 |
0.602 |
|
| 2020 |
Rai A, Doria-Rose VP, Silvestri GA, Yabroff KR. Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement. Journal of the National Cancer Institute. 111: 342-349. PMID 30698792 DOI: 10.1093/jnci/djy228 |
0.414 |
|
| 2019 |
Rendle KA, Burnett-Hartman AN, Neslund-Dudas C, Greenlee RT, Honda S, Elston Lafata J, Marcus PM, Cooley ME, Vachani A, Meza R, Oshiro C, Simoff MJ, Schnall M, Beaber EF, Doria-Rose VP, et al. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prevention Research (Philadelphia, Pa.). PMID 31871221 DOI: 10.1158/1940-6207.Capr-19-0378 |
0.38 |
|
| 2019 |
Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS. Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study. Plos One. 14: e0226027. PMID 31805156 DOI: 10.1371/Journal.Pone.0226027 |
0.769 |
|
| 2019 |
Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y. Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium. Egems (Washington, Dc). 7: 37. PMID 31531383 DOI: 10.5334/egems.296 |
0.658 |
|
| 2019 |
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, et al. Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. Journal of the National Cancer Institute. PMID 31292633 DOI: 10.1093/Jnci/Djz137 |
0.741 |
|
| 2019 |
Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS. Screening flexible sigmoidoscopy versus colonoscopy for reduction of colorectal cancer mortality. International Journal of Colorectal Disease. PMID 31152198 DOI: 10.1007/S00384-019-03300-7 |
0.758 |
|
| 2019 |
Doria-Rose VP, Kamineni A, Barrett MJ, Ko CW, Weiss NS. Case-Control Studies of the Efficacy of Screening Tests That Seek to Prevent Cancer Incidence: Results of an Approach That Utilizes Administrative Claims Data That Do Not Provide Information Regarding Test Indication. American Journal of Epidemiology. PMID 30698635 DOI: 10.1093/Aje/Kwy274 |
0.736 |
|
| 2018 |
Richards TB, Doria-Rose VP, Soman A, Klabunde CN, Caraballo RS, Gray SC, Houston KA, White MC. Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations. American Journal of Preventive Medicine. PMID 30467092 DOI: 10.1016/j.amepre.2018.07.030 |
0.4 |
|
| 2018 |
Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30459208 DOI: 10.1158/1055-9965.Epi-18-0452 |
0.607 |
|
| 2017 |
Gould MK, Sakoda LC, Ritzwoller DP, Simoff MJ, Neslund-Dudas CM, Kushi LH, Carter-Harris L, Feigelson HS, Minowada G, Doria-Rose VP. Monitoring Lung Cancer Screening Utilization and Outcomes in Four Cancer Research Network Sites. Annals of the American Thoracic Society. PMID 28683215 DOI: 10.1513/Annalsats.201703-237Oc |
0.659 |
|
| 2016 |
Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson JR, Mehta SJ, Becerra TA, Zhao WK, Schottinger J, Doria-Rose VP, Levin TR, Weiss NS, Fletcher RH. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. PMID 27733426 DOI: 10.1136/Gutjnl-2016-312712 |
0.663 |
|
| 2016 |
Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes & Control : Ccc. PMID 27639398 DOI: 10.1007/S10552-016-0808-4 |
0.4 |
|
| 2016 |
Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, et al. Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27507769 DOI: 10.1158/1055-9965.Epi-16-0555 |
0.536 |
|
| 2016 |
Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. Jama. PMID 27305518 DOI: 10.1001/jama.2016.6828 |
0.454 |
|
| 2016 |
Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB. Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? Clinical Trials (London, England). PMID 27006427 DOI: 10.1177/1740774516638345 |
0.423 |
|
| 2016 |
Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak C, Kuntz KM, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I. Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 26746432 DOI: 10.1177/0272989X15622642 |
0.343 |
|
| 2016 |
Doria-Rose VP, Sadoka LC, Neslund-Dudas CM, Ritzwoller DP, Feigelson HS, Simoff MJ, Kushi LH, Gould MK. Development of Data Infrastructure to Monitor Lung Cancer Screening Use and Outcomes in Four Cancer Research Network Sites Journal of Patient-Centered Research and Reviews. 3: 172. DOI: 10.17294/2330-0698.1287 |
0.425 |
|
| 2016 |
Doubeni CA, Corley D, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson J, Mehta SJ, Becerra T, Zhao WK, Schottinger JE, Doria-Rose VP, Levin TR, Weiss N, Fletcher R. 251 Screening Colonoscopy and the Risk of Death From Right and Left Colon Cancers Gastroenterology. 150: S61. DOI: 10.1016/S0016-5085(16)30325-0 |
0.629 |
|
| 2015 |
Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, et al. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. Journal of General Internal Medicine. PMID 26658934 DOI: 10.1007/S11606-015-3552-7 |
0.722 |
|
| 2015 |
Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, Williams AE, Weinmann S, Doria-Rose VP, Rutter CM. Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. Egems (Washington, Dc). 3: 1171. PMID 26290883 DOI: 10.13063/2327-9214.1171 |
0.64 |
|
| 2015 |
Goodman M, Fletcher RH, Doria-Rose VP, Jensen CD, Zebrowski AM, Becerra TA, Quinn VP, Zauber AG, Corley DA, Doubeni CA. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. Journal of Comparative Effectiveness Research. 1-11. PMID 26201973 DOI: 10.2217/Cer.15.39 |
0.566 |
|
| 2015 |
Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC. Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial. Journal of General Internal Medicine. PMID 25835747 DOI: 10.1007/S11606-015-3297-3 |
0.462 |
|
| 2015 |
Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, et al. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. Journal of the National Cancer Institute. 107. PMID 25688116 DOI: 10.1093/Jnci/Djv012 |
0.37 |
|
| 2015 |
Rutter CM, Knudsen AB, Atkin W, Marsh TL, Doria-Rose VP, Johnson EA, Pabiniak C, Wooldrage K, Kuntz KM, Ballegooijen Mv, Zauber AG, Lansdorp-Vogelaar I. Mo1996 Validation of Simulation Models to the UK Flexiscope Trial to Inform the Natural History of Colorectal Cancer Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)32605-6 |
0.464 |
|
| 2014 |
Doria-Rose VP, Levin TR, Palitz A, Conell C, Weiss NS. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. Gut. PMID 25512639 DOI: 10.1136/gutjnl-2014-307729 |
0.698 |
|
| 2014 |
Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012. Mmwr. Morbidity and Mortality Weekly Report. 63: 1004-9. PMID 25375072 |
0.518 |
|
| 2014 |
Fassil H, Adams KF, Weinmann S, Doria-Rose VP, Johnson E, Williams AE, Corley DA, Doubeni CA. Approaches for classifying the indications for colonoscopy using detailed clinical data. Bmc Cancer. 14: 95. PMID 24529031 DOI: 10.1186/1471-2407-14-95 |
0.367 |
|
| 2014 |
Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Cancer-Related News from the CDC Oncology Times. 36: 94. DOI: 10.1097/01.COT.0000459156.03204.B0 |
0.381 |
|
| 2013 |
Eldridge RC, Doubeni CA, Fletcher RH, Zauber AG, Corley DA, Doria-Rose VP, Goodman M. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. Journal of Medical Screening. 20: 198-207. PMID 24144847 DOI: 10.1177/0969141313508282 |
0.356 |
|
| 2013 |
Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS. Measurement in comparative effectiveness research. American Journal of Preventive Medicine. 44: 513-9. PMID 23597816 DOI: 10.1016/J.Amepre.2013.01.006 |
0.631 |
|
| 2013 |
Glasgow RE, Doria-Rose VP, Khoury MJ, Elzarrad M, Brown ML, Stange KC. Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain? Journal of the National Cancer Institute. 105: 766-73. PMID 23578853 DOI: 10.1093/Jnci/Djt066 |
0.399 |
|
| 2013 |
Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ. Factors associated with the risk of adenoma recurrence in distal and proximal colon. Digestion. 87: 141-6. PMID 23548665 DOI: 10.1159/000346281 |
0.338 |
|
| 2013 |
Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Annals of Internal Medicine. 158: 312-20. PMID 23460054 DOI: 10.7326/0003-4819-158-5-201303050-00003 |
0.731 |
|
| 2013 |
Doubeni CA, Weinmann S, Adams KF, Kamineni A, Buist DS, Ash AS, Rutter CM, Corley DA, Greenlee R, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, ... ... Doria-Rose VP, et al. Mo1566 Screening Colonoscopy and Risk of Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults: a Nested Case-Control Study Gastrointestinal Endoscopy. 77. DOI: 10.1016/J.Gie.2013.03.314 |
0.557 |
|
| 2012 |
Baxter NN, Warren JL, Barrett MJ, Stukel TA, Doria-Rose VP. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2664-9. PMID 22689809 DOI: 10.1200/JCO.2011.40.4772 |
0.49 |
|
| 2012 |
Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM. Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1049-59. PMID 22573798 DOI: 10.1158/1055-9965.EPI-12-0343 |
0.43 |
|
| 2012 |
Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, et al. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. Journal of the National Cancer Institute. 104: 280-9. PMID 22298838 DOI: 10.1093/Jnci/Djr549 |
0.517 |
|
| 2012 |
Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy Cancer Epidemiology. 36: 395-399. PMID 22112544 DOI: 10.1016/J.Canep.2011.10.013 |
0.572 |
|
| 2012 |
Adams K, Johnson E, Chubak J, Doubeni C, Kamineni A, Williams A, Weinmann S, Klabunde C, Doria-Rose VP, Rutter C. PS1-11: Development of an Algorithm to Classify Colonoscopy Indication Using CRN Health Plan Coded Data Clinical Medicine & Research. 10: 147-147. DOI: 10.3121/Cmr.2012.1100.Ps1-11 |
0.592 |
|
| 2011 |
Laiyemo AO, Doubeni C, Sanderson AK, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon Gastrointestinal Endoscopy. 74: 253-261. PMID 21549375 DOI: 10.1016/j.gie.2011.02.023 |
0.403 |
|
| 2011 |
Doria-Rose VP, Newcomb PA, Levin TR, Conell C, Weiss N. Risk Factors for Distal Colon and Rectal Cancer Following a Negative Screening Sigmoidoscopy Gastroenterology. 140: S-406. DOI: 10.1016/S0016-5085(11)61666-1 |
0.683 |
|
| 2011 |
Baxter NN, Warren J, Barrett MJ, Stukel T, Doria-Rose VP. The Association Between Colonoscopy and Colorectal Cancer Mortality in a U.S. Cohort According to Site of Cancer and Colonoscopist Specialty Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)60301-6 |
0.54 |
|
| 2011 |
Doria-Rose VP, Levin TR, Conell C, Newcomb PA, Weiss N. Is a Ten-Year Interval for Cancer Screening by Colorectal Endoscopy Appropriate? An Update From the Colorectal Cancer Prevention (CoCaP) Program Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)60061-9 |
0.714 |
|
| 2010 |
Doria-Rose VP, Vinden C, Ransohoff DF, Prorok PC. Flexible sigmoidoscopy to prevent colorectal cancer. Lancet (London, England). 376: 871; author reply 87. PMID 20833296 DOI: 10.1016/S0140-6736(10)61407-9 |
0.525 |
|
| 2010 |
Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. Journal of the National Cancer Institute. 102: 538-46. PMID 20357245 DOI: 10.1093/Jnci/Djq068 |
0.462 |
|
| 2010 |
Laiyemo AO, Doubeni C, Pinsky P, Doria-Rose VP, Bresalier RS, Weissfeld J, Schoen RE, Marcus P, Prorok PC, Berg C. T1407: Factors Associated With Inadequate Colorectal Cancer Screening With Flexible Sigmoidoscopy Gastrointestinal Endoscopy. 71. DOI: 10.1016/J.Gie.2010.03.620 |
0.58 |
|
| 2009 |
Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer. 115: 5007-17. PMID 19637354 DOI: 10.1002/Cncr.24545 |
0.432 |
|
| 2009 |
Weiss NS, Doria-Rose VP. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Annals of Internal Medicine. 150: 817-8; author reply . PMID 19487720 |
0.602 |
|
| 2009 |
Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A. Hormone therapy in relation to survival from large bowel cancer. Cancer Causes & Control : Ccc. 20: 409-16. PMID 18998219 DOI: 10.1007/s10552-008-9255-1 |
0.386 |
|
| 2009 |
Laiyemo AO, Doubeni C, Pinsky P, Doria-Rose VP, Bresalier RS, Lamerato L, Crawford D, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus P, Prorok PC, et al. Race-Ethnicity and Colorectal Cancer Disparities: Is There a Difference in Adenoma Initiation? Evidence from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Gastrointestinal Endoscopy. 69: AB275. DOI: 10.1016/J.Gie.2009.03.734 |
0.582 |
|
| 2006 |
Weiss NS, Doria-Rose VP. Colorectal cancer risk following a negative colonoscopy. Jama. 296: 2436-7; author reply. PMID 17119135 DOI: 10.1001/jama.296.20.2436-b |
0.627 |
|
| 2006 |
Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes & Control : Ccc. 17: 63-70. PMID 16411054 DOI: 10.1007/S10552-005-0360-0 |
0.391 |
|
| 2005 |
Doria-Rose VP, Biggs ML, Weiss NS. Subfertility and the risk of testicular germ cell tumors (United States). Cancer Causes & Control : Ccc. 16: 651-6. PMID 16049803 DOI: 10.1007/s10552-005-0169-x |
0.465 |
|
| 2005 |
Doria-Rose VP, Newcomb PA, Levin TR. Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer Gut. 54: 1273-1278. PMID 15871999 DOI: 10.1136/Gut.2005.064030 |
0.42 |
|
| 2004 |
Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology. 127: 714-22. PMID 15362026 DOI: 10.1053/J.Gastro.2004.06.048 |
0.664 |
|
| Show low-probability matches. |